Home › USFDA Tracker › Aarti Drugs
Aarti Drugs — USFDA Status
Inspections, Form 483 observations, OAI classifications, warning letters, import alerts and approvals for Aarti Drugs (NSE: AARTIDRUGS, BSE: 524348), from US FDA records and exchange filings.
50
Compliance score (5 years) · how
1
USFDA-inspected plants on record
0
OAI classifications (5y)
0
Form 483s on record (5y)
0
Open warning letters
Latest USFDA record: USFDA inspection classified VAI — 20 Sep 2024 (Palghar plant). Source: FDA Data Dashboard.
USFDA events by year
2015
2024
NAIVAIForm 483OAIWarning letterImport alertUS approval
Plants
| Plant | FEI | Latest result | Last inspection | History (newest first) |
|---|---|---|---|---|
| Palghar Aarti Drugs Limited |
3006418686 | VAI | 20 Sep 2024 |
Full USFDA timeline
20 Sep 2024
VAI — minor issues
USFDA inspection classified VAI
Palghar · FEI 3006418686 · Aarti Drugs Limited, Palghar — Drug Quality Assurance (Drugs)
Source: FDA Data Dashboard ↗
23 Mar 2015
Import alert
Added to FDA import alert 66-40
Aarti Drugs Ltd, Midc Plot No E21, Tarapur, Maharashtra INDIA
Source: FDA import alerts ↗
📎 Cite this data: Source: PharmaRoz analysis of FDA inspection data and exchange filings, updated 12 Nov 2026 — https://pharmaroz.com/company/aarti-drugs